{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:04:59Z","timestamp":1789049099989,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11596-012-0050-6","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T09:17:34Z","timestamp":1334827054000},"page":"287-290","source":"Crossref","is-referenced-by-count":12,"title":["Expression of IRF-4 and IBP in skin lesions of patients with psoriasis vulgaris"],"prefix":"10.1007","volume":"32","author":[{"given":"Anhong","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanjuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,20]]},"reference":[{"issue":"12","key":"50_CR1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","volume":"10","author":"J.H. Buckner","year":"2010","unstructured":"Buckner JH. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases. Nat Rev Immunol, 2010,10(12):849\u2013859","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"50_CR2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","volume":"28","author":"W. Ouyang","year":"2008","unstructured":"Ouyang W, Kolls JK, Zheng Y, et al. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity, 2008,28(4):454\u2013467","journal-title":"Immunity"},{"issue":"6","key":"50_CR3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A. Cesare Di","year":"2009","unstructured":"Di Cesare A, Di Meglio P, Nestle FO, et al. The IL-23\/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol, 2009,129(6):1339\u20131350","journal-title":"J Invest Dermatol"},{"issue":"9","key":"50_CR4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni1500","volume":"8","author":"A. Br\u00fcstle","year":"2007","unstructured":"Br\u00fcstle A, Heink S, Huber M, et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol, 2007,8(9):958\u2013966","journal-title":"Nat Immunol"},{"issue":"4","key":"50_CR5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0198-8859(03)00024-7","volume":"64","author":"S. Gupta","year":"2003","unstructured":"Gupta S, Lee A, Hu C, et al. Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. Hum Immunol, 2003,64(4):389\u2013401","journal-title":"Hum Immunol"},{"issue":"6","key":"50_CR6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2008.10.011","volume":"29","author":"Q. Chen","year":"2008","unstructured":"Chen Q, Yang W, Gupta S, et al. IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of irf-4 transcription factor. Immunity, 2008,29(6):899\u2013911","journal-title":"Immunity"},{"issue":"11","key":"50_CR7","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.4049\/jimmunol.0902573","volume":"183","author":"A.J. Canonigo-Balancio","year":"2009","unstructured":"Canonigo-Balancio AJ, Fos C, Prod\u2019homme T, et al. SLAT\/Def6 plays a critical role in the development of th17 cell-mediated experimental autoimmune encephalomyelitis. J Immunol, 2009,183(11):7259\u20137267","journal-title":"J Immunol"},{"issue":"5","key":"50_CR8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"M.A. Lowes","year":"2008","unstructured":"Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol, 2008,128(5):1207\u20131211","journal-title":"J Invest Dermatol"},{"issue":"3","key":"50_CR9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11596-007-0329-1","volume":"27","author":"J. Li","year":"2007","unstructured":"Li J, Chen X, Liu Z, et al. Expression of Th17 cytokines in skin lesions of patients with psoriasis. Huazhong Univ Sci Technolog [Med Sci], 2007,27(3):330\u2013332","journal-title":"Huazhong Univ Sci Technolog [Med Sci]"},{"issue":"52","key":"50_CR10","doi-asserted-by":"crossref","first-page":"20 846","DOI":"10.1073\/pnas.0809077106","volume":"105","author":"M. Huber","year":"2008","unstructured":"Huber M, Br\u00fcstle A, Reinhard K, et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci USA, 2008,105(52):20 846\u201320 851","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"50_CR11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nm.1995","volume":"15","author":"R. Caruso","year":"2009","unstructured":"Caruso R, Botti E, Sarra M, et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med, 2009,15(9):1013\u20131015","journal-title":"Nat Med"},{"issue":"9","key":"50_CR12","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/1078-0432.CCR-08-1845","volume":"15","author":"A.L. Shaffer","year":"2009","unstructured":"Shaffer AL, Emre NC, Romesser PB, et al. IRF4: Immunity. Malignancy! Therapy? Clin Cancer Res, 2009, 15(9):2954\u201361","journal-title":"Clin Cancer Res"},{"issue":"4","key":"50_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/PAI.0b013e3181cf1126","volume":"18","author":"G. Gualco","year":"2010","unstructured":"Gualco G, Weiss LM, Bacchi CE. MUM1\/IRF4: A review. Appl Immunohistochem Mol Morphol, 2010,18(4): 301\u2013310","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"50_CR14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.0105-2896.2009.00864.x","volume":"233","author":"P.S. Biswas","year":"2010","unstructured":"Biswas PS, Bhagat G, Pernis AB. IRF-4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol Rev, 2010,233(1):79\u201396","journal-title":"Immunol Rev"},{"issue":"3","key":"50_CR15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI24096","volume":"116","author":"J.C. Fanzo","year":"2006","unstructured":"Fanzo JC, Yang W, Jang SY, et al. Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity. J Clin Invest, 2006,116(3):703\u2013714","journal-title":"J Clin Invest"},{"issue":"4","key":"50_CR16","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","volume":"181","author":"S. Xiao","year":"2008","unstructured":"Xiao S, Jin H, Korn T, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol, 2008,181(4):2277\u20132284","journal-title":"J Immunol"},{"issue":"9","key":"50_CR17","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1172\/JCI42856","volume":"120","author":"P.S. Biswas","year":"2010","unstructured":"Biswas PS, Gupta S, Chang E, et al. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest, 2010,120(9):3280\u20133295","journal-title":"J Clin Invest"},{"issue":"6","key":"50_CR18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.immuni.2008.12.001","volume":"29","author":"R.I. Nurieva","year":"2008","unstructured":"Nurieva RI, Dong C. Keeping autoimmunity in check: How to control a Th17 cell controller. Immunity, 2008,29(6):841\u2013843","journal-title":"Immunity"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-012-0050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-012-0050-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-012-0050-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:15:12Z","timestamp":1559409312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-012-0050-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["50"],"URL":"https:\/\/doi.org\/10.1007\/s11596-012-0050-6","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}